Funded

OneOme

About

OneOme’s RightMed pharmacogenomic test helps healthcare providers with timely, evidence-based prescription decisions by combining a patient’s genetic profile and current medications in an interactive report that easily integrates into current practices. OneOme’s RightMed test covers cardiovascular disease, cancer, chronic pain, diabetes, psychiatric conditions, and more. The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. 

An Invenshure portfolio company